GNOM Stock: Global X Genomics & Biotechnology ETF Stock Price, Analysis & Insights
Get live gnom stock price $46.20, comprehensive Global X Genomics & Biotechnology ETF stock analysis, charts, news, and expert forecast. Real-time gnom stock data and investment insights.
Loading chart...
Company Overview
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Financial Services sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 1.80)
Business Model & Strategy
Global X Genomics & Biotechnology ETF operates in the Asset Management - Global industry, focusing on financial intermediation, banking services, and investment management. The company the company navigates Financial Services sector dynamics while pursuing growth opportunities. The Asset Management - Global model requires risk management, regulatory compliance, and customer trust to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Global X Genomics & Biotechnology ETF competes in the Asset Management - Global within the broader Financial Services. With 54.3 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Financial Services is characterized by economic cycles, regulatory evolution, and digital transformation. As a publicly traded company on the NASDAQ Global Market, Global X Genomics & Biotechnology ETF provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Global X Genomics & Biotechnology ETF should consider industry-specific trends, competitive positioning, and Financial Services sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Global X Genomics & Biotechnology ETF shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Financial Services may affect company performance
- ⚠Past performance does not guarantee future results for Global X Genomics & Biotechnology ETF
- ⚠Investors should consider how Global X Genomics & Biotechnology ETF fits within their overall portfolio allocation
Market Cap
54.27M
Beta
1.80
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Financial Services leader with 54.27M market capitalization
- Trading Volume: 732 shares traded today
- Price Range: 52-week range of $27.20 - $47.82
- Exchange: Listed on NASDAQ Global Market
Financial Metrics
Market Analysis for Global X Genomics & Biotechnology ETF
Global X Genomics & Biotechnology ETF (GNOM) operates in the Asset Management - Global industry within the Financial Services sector. With a current market capitalization of 54.27M, the company represents a significant player in its market. The stock is currently trading at $46.20 with a negativedaily change of 0.07%.
The company's substantial employee base and presence on the NASDAQ Global Marketexchange position it as a Financial Services sector leader. Investors should consider the stock's P/E ratio of N/A, beta of 1.80, and 52-week price range from $27.20 to $47.82when evaluating investment opportunities.
Why Invest in Global X Genomics & Biotechnology ETF?
Strengths
- • Established market presence in Financial Services
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Market)
- • Experienced leadership under
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Financial Services Stocks
About Financial Services Sector
The Financial Services sector includes companies that provide banking, insurance, investment, and other financial services to consumers and businesses.
